Drug Guide
Minocycline Hydrochloride
Classification
Therapeutic: Antibiotic, Tetracycline class
Pharmacological: Tetracycline antibiotic mechanism of action
FDA Approved Indications
- Acne vulgaris
- Periodontal infections (Arestin)
- Respiratory tract infections
- Urinary tract infections
- Skin infections
Mechanism of Action
Inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing addition of amino acids to growing peptide chains, leading to bacteriostatic effects.
Dosage and Administration
Adult: Dose varies based on condition; e.g., for acne: 50-100 mg once or twice daily.
Pediatric: Typically used for children ≥8 years; dose based on weight.
Geriatric: Adjusted based on renal and hepatic function, monitor for increased adverse effects.
Renal Impairment: Use with caution; dose adjustment may be necessary.
Hepatic Impairment: Use cautiously; monitor liver function
Pharmacokinetics
Absorption: Well absorbed orally, slightly affected by food.
Distribution: Widely distributed in body tissues and fluids.
Metabolism: Minimal hepatic metabolism.
Excretion: Primarily via bile and feces; some renal excretion.
Half Life: Approx. 11-22 hours, depending on renal function.
Contraindications
- Hypersensitivity to tetracyclines
- Pregnancy (especially during the last half of pregnancy), lactation, children <8 years due to teeth discoloration and bone growth inhibition.
Precautions
- Use with caution in patients with hepatic or renal impairment.
- Photosensitivity risk.
Adverse Reactions - Common
- Gastrointestinal upset (Common)
- Dizziness, vertigo (Common)
- Photosensitivity (Common)
Adverse Reactions - Serious
- Drug-induced lupus erythematosus (Rare)
- Vestibular toxicity (dizziness, vertigo) at higher doses (Rare)
- Hepatotoxicity (Rare)
- Serum sickness (Rare)
Drug-Drug Interactions
- Penicillins (may inactivate minocycline)
- Retinoids (risk of intracranial hypertension)
- Oral contraceptives (reduced efficacy)
Drug-Food Interactions
- Dairy products, calcium, magnesium, aluminum-containing antacids, and iron supplements (decrease absorption)
Drug-Herb Interactions
N/ANursing Implications
Assessment: Monitor for signs of superinfection, gastrointestinal disturbances, and photosensitivity.
Diagnoses:
- Risk for infection related to antibiotic use
- Risk for photosensitivity skin reaction
Implementation: Administer with food to minimize gastrointestinal upset, but avoid dairy or antacids close to the dose time.
Evaluation: Assess for decrease in infection Signs/Symptoms, monitor for adverse effects.
Patient/Family Teaching
- Take medication exactly as prescribed.
- Avoid excessive sun exposure and use sunscreen.
- Avoid taking with dairy products, antacids, or iron supplements at the same time.
- Report any severe side effects or allergic reactions.
Special Considerations
Black Box Warnings:
- Vestibular disturbances at high doses.
- Permanent tooth discoloration and inhibition of bone growth in children under 8 years.
- Photosensitivity risk.
Genetic Factors: None specific.
Lab Test Interference: May affect results of serum bilirubin, liver function tests, and urine studies.
Overdose Management
Signs/Symptoms: Gastrointestinal symptoms such as nausea, vomiting, diarrhea; dizziness; vertigo.
Treatment: Supportive care, gastric lavage if recent ingestion, and monitoring. Dialysis is rarely necessary.
Storage and Handling
Storage: Store at room temperature, 20-25°C (68-77°F).
Stability: Stable under recommended storage conditions.